Tue, Mar 19, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Alternative Market Briefing

Healthcare private equity posts highest ever deal value in 2019

Friday, March 13, 2020

Bailey McCann, Opalesque New York:

Healthcare private equity had a robust 2019. Total disclosed deal value reached $78.9 billion, the highest on record, and the deal count of 313 was in line with the 316 deals of 2018, according to new data from Bain and Company.

Healthcare private equity also outperformed all other sectors of private equity activity representing 18% of all disclosed deal value. The most active market was in the US.

Along with deal activity, healthcare exits also posted a banner year. Disclosed deal values rose 29% to $40.8 billion and count rose 13% to 126.

The average deal size rose roughly 25% as funds focused more on larger assets. There were 27 deals greater than $1 billion in value in 2019, compared with 18 such deals in 2018. Biopharma had an exceptional year as disclosed value grew 146% to $40.7 billion. HCIT across sectors also excelled, with value doubling to $17.5 billion.

The increase in deal size represents increased investor confidence in healthcare companies overall. 2019 also saw the largest buyout deal in over a decade with the $10.1 billion acquisition of Nestlé Skin Health by EQT and Abu Dhabi Investment Authority. This deal was especially notable as overall deal size in other sectors has declined as private equity firms face stiffer competition and high valuations.

Looking ahead, Bain & Company expects that deal flow in the healthcare sector will remain strong. Increased worldwide demand for healthcare services was......................

To view our full article Click here

Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1